XLV · ARCA · ETF
State Street Health Care Select Sector SPDR ETF (XLV) Price, Holdings & Fees
State Street Health Care Select Sector SPDR ETF (XLV) closed at $593.34 on Oct 9, 2026, up 0.52% from the previous close of $590.25.
Share price, past year
1Y +8.81%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $593.34 |
| Sep 30, 2026 | $573.00 |
| Aug 31, 2026 | $541.95 |
| Jul 31, 2026 | $544.82 |
| Jun 30, 2026 | $563.32 |
| May 29, 2026 | $568.10 |
| Apr 30, 2026 | $588.73 |
| Mar 31, 2026 | $598.27 |
| Feb 27, 2026 | $623.14 |
| Jan 30, 2026 | $609.83 |
| Dec 31, 2025 | $617.29 |
| Nov 28, 2025 | $577.93 |
| Oct 31, 2025 | $574.05 |
Key statistics
- Expense ratio
- 0.08%
- as of Sep 30, 2025
- Net assets
- $40.6B
- as of Jun 30, 2026
- Holdings
- 65
- as of Jun 30, 2026
- 52-week range
- $524.95 – $639.82
State Street Health Care Select Sector SPDR ETF's expense ratio is 0.08%: $8.00 a year on $10,000 invested.
Holdings
State Street Health Care Select Sector SPDR ETF held 65 investments worth $40.60B as of Jun 30, 2026. Its largest holding was Eli Lilly & Co, at 16.51% of the fund.
| # | Holding | % of fund | Value |
|---|---|---|---|
| 1 | Eli Lilly & Co | 16.51% | $6.70B |
| 2 | Johnson & Johnson | 10.64% | $4.32B |
| 3 | AbbVie Inc | 7.74% | $3.14B |
| 4 | UnitedHealth Group Inc | 6.57% | $2.67B |
| 5 | Merck & Co Inc | 5.52% | $2.24B |
| 6 | Amgen Inc | 3.40% | $1.38B |
| 7 | Thermo Fisher Scientific Inc | 3.24% | $1.32B |
| 8 | Abbott Laboratories | 2.75% | $1.12B |
| 9 | Gilead Sciences Inc | 2.73% | $1.11B |
| 10 | Intuitive Surgical Inc | 2.45% | $995.03M |
| 11 | Pfizer Inc | 2.39% | $969.58M |
| 12 | CVS Health Corp | 2.30% | $932.50M |
| 13 | Vertex Pharmaceuticals Inc | 2.19% | $890.68M |
| 14 | Danaher Corp | 2.09% | $847.68M |
| 15 | Bristol-Myers Squibb Co | 2.05% | $831.26M |
| 16 | Stryker Corp | 1.89% | $767.42M |
| 17 | Medtronic PLC | 1.75% | $709.56M |
| 18 | McKesson Corp | 1.58% | $641.66M |
| 19 | Elevance Health Inc | 1.46% | $593.33M |
| 20 | Cigna Group/The | 1.27% | $515.19M |
| 21 | Boston Scientific Corp | 1.10% | $448.17M |
| 22 | Regeneron Pharmaceuticals Inc | 1.08% | $440.15M |
| 23 | HCA Healthcare Inc | 1.05% | $427.73M |
| 24 | Cardinal Health Inc | 0.97% | $393.05M |
| 25 | Cencora Inc | 0.96% | $388.94M |
Top 25 of 65 holdings, as of Jun 30, 2026. Percentages are of the fund's net assets.
What the fund owns
| Asset type | % of fund |
|---|---|
| Stocks | 99.68% |
| Cash and short-term investments | 0.26% |
| Derivatives | 0.01% |
| Country | % of fund |
|---|---|
| United States | 97.85% |
| Ireland | 2.11% |
Shares of net assets from the fund's N-PORT report. Funds that borrow can add up to more than 100%, with borrowing (such as repurchase agreements) shown as a negative share.
Monthly total returns
Over the 3 months to Jun 30, 2026, State Street Health Care Select Sector SPDR ETF's total return was +8.73%, as reported to the SEC.
| Month | Total return |
|---|---|
| Jun 30, 2026 | +6.60% |
| May 31, 2026 | +2.47% |
| Apr 30, 2026 | −0.46% |
The fund's own total returns as reported to the SEC (N-PORT), including reinvested distributions. Not the sample prices above.
Fund profile
- Name
- State Street Health Care Select Sector SPDR ETF
- Ticker
- XLV
- Exchange
- ARCA
- Fund type
- ETF
- Trust
- SELECT SECTOR SPDR TRUST
- SEC series ID
- S000006412
- SEC CIK
- 0001064641
- Fractional shares
- Yes
Recent SEC filings
- Aug 28, 2026
- Sep 3, 2026
- Jun 4, 2026
- 485BPOSProspectus updateApr 24, 2026
- Mar 6, 2026
- 485BPOSProspectus updateJan 28, 2026
- Dec 5, 2025
- 485BPOSProspectus updateJul 29, 2025
Shareholder reports and prospectuses are filed by SELECT SECTOR SPDR TRUST, the trust behind State Street Health Care Select Sector SPDR ETF, and cover all of its funds.
Frequently asked questions
What is XLV's price?
State Street Health Care Select Sector SPDR ETF (XLV) closed at $593.34 on Oct 9, 2026, up 0.52% from the previous close of $590.25.
What is XLV's expense ratio?
State Street Health Care Select Sector SPDR ETF's expense ratio is 0.08%: $8.00 a year on $10,000 invested.
What does XLV hold?
State Street Health Care Select Sector SPDR ETF held 65 investments worth $40.60B as of Jun 30, 2026. Its largest holding was Eli Lilly & Co, at 16.51% of the fund. Its five largest holdings were Eli Lilly & Co, Johnson & Johnson, AbbVie Inc, UnitedHealth Group Inc, Merck & Co Inc.
How has XLV performed?
Over the 3 months to Jun 30, 2026, State Street Health Care Select Sector SPDR ETF's total return was +8.73%, as reported to the SEC.
Sources and methodology
Holdings, net assets and monthly returns come from the fund's N-PORT filing with the SEC, as of Jun 30, 2026 (filed Aug 28, 2026). The expense ratio is from the fund's prospectus or shareholder report, as of Sep 30, 2025. Prices are generated sample data for development. Data sources and disclosures